• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

‘Masterclass’: Bondi flips script on Dem senator after suggesting she will weaponize DOJ

by January 15, 2025
written by January 15, 2025

Conservatives on social media celebrated President-elect Trump’s attorney general nominee Pam Bondi’s response to a question from Sen. Sheldon Whitehouse, D-R.I., during her confirmation hearing on Wednesday. 

‘It would not be appropriate for a prosecutor to start with a name and look for a crime?’ Whitehouse said during his line of questioning. ‘It’s a prosecutor’s job to start with a crime and look for a name. Correct?’

Bondi responded by highlighting the federal government’s investigations into Trump.

‘Senator, I think that is the whole problem with the weaponization that we have seen the last four years and what’s been happening to Donald Trump,’ Bondi said. 

‘They targeted Donald Trump. They went after him, actually starting back in 2016. They targeted his campaign. They have launched countless investigations against him. That will not be the case. If I am attorney general, I will not politicize that office,’ Bondi said. ‘I will not target people simply because of their political affiliation. Justice will be administered evenhandedly throughout this country. Senator, we’ve got to bring this country back together. We’ve got to move forward, or we’re going to lose our country.’

Conservatives on social media quickly took notice of the exchange. 

‘Pam Bondi totally flips the script on Senator Sheldon Whitehouse (D) who tried to make it seem like she will weaponize the DOJ,’ Florida’s Voice News assistant news director Eric Daughtery posted on X. ‘Masterclass.’

‘Pam Bondi is making Sheldon Whitehouse look stupid,’ Trump ’24 deputy rapid response director Greg Price posted on X. 

‘Senator Whitehouse unironically explaining that prosecutors should have a crime and then look for a suspect, not the other way around,’ Fox News contributor Katie Pavlich posted on X. 

‘Bondi responds by explaining DOJ did the opposite to Trump for years.’

Fox News Digital reached out to Whitehouse’s office but did not immediately receive a response.

Bondi is expected to be confirmed by the U.S. Senate and some have speculated that she will earn some votes from Democrats. 

Related Topics

Politics
Senate Hearings
Senate
Trump Transition

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Democrats and Republicans criticize Biden admin’s Cuba detente
next post
Government agencies concerned Trump inauguration ‘potential target’ for extremists: report

related articles

US submarine sinks Iranian warship by torpedo in...

March 4, 2026

MIKE DAVIS: The unsung, but crucial foot soldiers...

March 4, 2026

Israel says fighter jet took down Iranian warplane,...

March 4, 2026

Minnesota GOP lawmaker urges Congress to press Walz...

March 4, 2026

Former MLB star Mark Teixeira wins GOP primary...

March 4, 2026

Noem preps to battle House Dems after bipartisan...

March 4, 2026

Rising star Talarico topples progressive firebrand Crockett in...

March 4, 2026

Iran’s drone swarm attacks unleash ‘exponential costs’ on...

March 4, 2026

Iran’s senior clerics ‘exposed’ after building strike in...

March 4, 2026

Trump says he might have ‘forced Israel’s hand’...

March 4, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump admin planning to consolidate HIV programs, slashing ‘overhead’ and DEI: official

    March 19, 2025
  • House passes Trump-backed plan to avert government shutdown

    September 19, 2025
  • Kamala Harris is the most left wing major party candidate for the presidency in post-World War II America

    August 27, 2024
  • Why is AMD stock plunging sharply on Thursday?

    January 9, 2026
  • President Trump takes on ‘Big Pharma’ by signing executive order to lower drug prices

    May 12, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,246)
  • Investing (1,049)
  • Stock (979)

Latest Posts

  • DOJ restores Trump photo to Epstein files after determining no victims depicted

    December 22, 2025
  • Amazon expects to cut corporate jobs as it relies more on AI

    June 18, 2025
  • New report warns NATO’s data vulnerabilities could cost lives without US fix

    May 3, 2025

Recent Posts

  • AI is reshaping business. This is how we stay ahead of China

    December 24, 2024
  • IKEA to close large China stores as property slump reshapes retail strategy

    January 7, 2026
  • Boeing would avoid guilty plea, prosecution over 737 Max crashes in possible DOJ deal

    May 17, 2025

Editor’s Pick

  • US and Israel urgently need to replenish weapons stockpiles after 12-day war, defense analysts warn

    July 24, 2025
  • Albanian judge killed in courtroom shooting amid growing anger over justice system reforms

    October 11, 2025
  • Venezuelan military jets buzz US Navy ship in ‘highly provocative’ move, Pentagon says

    September 5, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock